BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 32916398)

  • 21. Venous thromboembolism in cancer patients.
    Deng A; Galanis T; Graham MG
    Hosp Pract (1995); 2014 Dec; 42(5):24-33. PubMed ID: 25485915
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk of intracranial hemorrhage with anticoagulation therapy in melanoma patients with brain metastases.
    Alvarado G; Noor R; Bassett R; Papadopoulos NE; Kim KB; Hwu WJ; Bedikian A; Patel S; Hwu P; Davies MA
    Melanoma Res; 2012 Aug; 22(4):310-5. PubMed ID: 22584956
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of Ischemic Stroke, Major Bleeding, and Other Adverse Events With Warfarin Use vs Non-vitamin K Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation With a History of Intracranial Hemorrhage.
    Tsai CT; Liao JN; Chiang CE; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chung FP; Chao TF; Lip GYH; Chen SA
    JAMA Netw Open; 2020 Jun; 3(6):e206424. PubMed ID: 32478848
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral anticoagulants for primary prevention, treatment and secondary prevention of venous thromboembolic disease, and for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis and cost-effectiveness analysis.
    Sterne JA; Bodalia PN; Bryden PA; Davies PA; López-López JA; Okoli GN; Thom HH; Caldwell DM; Dias S; Eaton D; Higgins JP; Hollingworth W; Salisbury C; Savović J; Sofat R; Stephens-Boal A; Welton NJ; Hingorani AD
    Health Technol Assess; 2017 Mar; 21(9):1-386. PubMed ID: 28279251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemical venous thromboembolic prophylaxis is safe and effective for patients with traumatic brain injury when started 24 hours after the absence of hemorrhage progression on head CT.
    Saadeh Y; Gohil K; Bill C; Smith C; Morrison C; Mosher B; Schneider P; Stevens P; Kepros JP
    J Trauma Acute Care Surg; 2012 Aug; 73(2):426-30. PubMed ID: 22846950
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Periprocedural interruption of anticoagulation in patients with cancer-associated venous thromboembolism: An analysis of thrombotic and bleeding outcomes.
    Shaw JR; Douketis J; Le Gal G; Carrier M
    J Thromb Haemost; 2019 Jul; 17(7):1171-1178. PubMed ID: 31038838
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of Anticoagulation on Hospitalization Costs After Intracranial Hemorrhage in Atrial Fibrillation: A Registry Study.
    Vestergaard AS; Skjøth F; Lip GY; Larsen TB
    Stroke; 2016 Apr; 47(4):979-85. PubMed ID: 26883499
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Length of Thromboprophylaxis in Patients Operated on for a High-Grade Glioma: A Retrospective Study.
    Senders JT; Snijders TJ; van Essen M; van Bentum GM; Seute T; de Vos FY; Smith TR; Robe PA; Broekman MLD
    World Neurosurg; 2018 Jul; 115():e723-e730. PubMed ID: 29715571
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intracranial hemorrhage in patients with brain metastases treated with therapeutic enoxaparin: a matched cohort study.
    Donato J; Campigotto F; Uhlmann EJ; Coletti E; Neuberg D; Weber GM; Zwicker JI
    Blood; 2015 Jul; 126(4):494-9. PubMed ID: 25987658
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence of venous thromboembolism and hemorrhage related safety studies of preoperative anticoagulation therapy in hip fracture patients undergoing surgical treatment: a case-control study.
    Liu Z; Han N; Xu H; Fu Z; Zhang D; Wang T; Jiang B
    BMC Musculoskelet Disord; 2016 Feb; 17():76. PubMed ID: 26873584
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Challenges in anticoagulation for patients with brain tumors.
    Iyengar V; Patell R; Zwicker J
    Best Pract Res Clin Haematol; 2022 Mar; 35(1):101350. PubMed ID: 36030073
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bleeding, Recurrent Venous Thromboembolism, and Mortality Risks During Warfarin Interruption for Invasive Procedures.
    Clark NP; Witt DM; Davies LE; Saito EM; McCool KH; Douketis JD; Metz KR; Delate T
    JAMA Intern Med; 2015 Jul; 175(7):1163-8. PubMed ID: 26010033
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Venous Thrombotic Events and Anticoagulation in Brain Tumor Patients.
    Diaz M; Jo J
    Curr Oncol Rep; 2022 Apr; 24(4):493-500. PubMed ID: 35179708
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic Anticoagulation in Patients with Primary Brain Tumors or Secondary Brain Metastasis.
    Lin RJ; Green DL; Shah GL
    Oncologist; 2018 Apr; 23(4):468-473. PubMed ID: 29158366
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness and safety of rivaroxaban versus warfarin for treatment and prevention of recurrence of venous thromboembolism.
    Coleman CI; Bunz TJ; Turpie AGG
    Thromb Haemost; 2017 Oct; 117(10):1841-1847. PubMed ID: 28640322
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is anticoagulation for venous thromboembolism safe for Asian elective neurosurgical patients? A single centre study.
    Cheang MY; Yeo TT; Chou N; Lwin S; Ng ZX
    ANZ J Surg; 2019 Jul; 89(7-8):919-924. PubMed ID: 31293073
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intracranial hemorrhage after head injury among older patients on anticoagulation seen in the emergency department: a population-based cohort study.
    Grewal K; Atzema CL; Austin PC; de Wit K; Sharma S; Mittmann N; Borgundvaag B; McLeod SL
    CMAJ; 2021 Oct; 193(40):E1561-E1567. PubMed ID: 35040805
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Early venous thromboembolic event prophylaxis in traumatic brain injury with low-molecular-weight heparin: risks and benefits.
    Dudley RR; Aziz I; Bonnici A; Saluja RS; Lamoureux J; Kalmovitch B; Gursahaney A; Razek T; Maleki M; Marcoux J
    J Neurotrauma; 2010 Dec; 27(12):2165-72. PubMed ID: 20939698
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ultra-Early Venous Thromboembolism (VTE) Prophylaxis in Spontaneous Intracerebral Hemorrhage (sICH).
    Kananeh MF; Fonseca-Paricio MJ; Liang JW; Sullivan LT; Sharma K; Shah SO; Vibbert MD
    J Stroke Cerebrovasc Dis; 2021 Feb; 30(2):105476. PubMed ID: 33253987
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparing Length of Stay Between Patients Taking Rivaroxaban and Conventional Anticoagulants for Treatment of Venous Thromboembolism.
    Desai A; Desai A; Calixte R; Aparnath M; Hindenburg A; Salzman S; Mathew JP
    Lung; 2016 Aug; 194(4):605-11. PubMed ID: 27192990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.